NSE/BSE Codes: NSE Symbol: 5PAISA, BSE Scrip Code: 540776
Summary of Key Information:
Nature of Event / Disclosure:
Regulatory disclosure pursuant to Regulation 30 of SEBI Listing Regulations regarding the outcome of an income tax appeal.
Involved Parties / Authorities:
- Appellant: 5paisa Capital Limited
- Adjudicating Authority: Commissioner of Income Tax (Appeals)-54, Mumbai (CIT(A))
- Original Assessing Authority: National Faceless Assessment Centre (NFAC), Delhi
Date / Timeline of Event:
- Assessment Year: 2023-24
- Original NFAC Order Date: Passed under Section 143(3) read with Section 144B of the Income Tax Act, 1961 (exact date not specified in disclosure)
- CIT(A) Order Date: October 28, 2026
- Disclosure Filing Date: October 29, 2026
Brief Description of Outcome / Dispute:
The company filed an appeal against an income tax assessment order from NFAC, Delhi which had made additions/disallowances aggregating to ₹42.90 crore for Assessment Year 2023-24. The CIT(A) has partly allowed the appeal, granting substantial relief to the company.
Impact of Outcome:
Financial Impact:
- Total Original Disputed Amount: ₹42.90 crore in additions/disallowances
- Relief Granted by CIT(A): ₹40.03 crore
- Sustained Disallowance: ₹2.87 crore
- No penalties or compensation were imposed as part of this order
- The sustained amount of ₹2.87 crore represents the remaining financial impact on the company
Operational / Business / Strategic Impact:
The company states it has "sufficient documentation in support of remaining disallowance" and will take necessary action before the Adjudicating Authority within prescribed timelines. The favorable outcome reduces potential tax liability significantly.
Other Implications:
The disclosure demonstrates the company's commitment to regulatory compliance and corporate governance standards as required under SEBI Listing Regulations.
Next Steps / Required Actions:
The company will pursue further action on the remaining ₹2.87 crore disallowance before the appropriate Adjudicating Authority within the prescribed timelines.